Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dengue Shock Syndrome”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Early research (Phase 1)Study completedNCT00919178
What this trial is testing

Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus

Who this might be right for
Dengue Shock SyndromeDengue Hemorrhagic Fever
National Institute of Allergy and Infectious Diseases (NIAID) 70
Not applicableStudy completedNCT04023708
What this trial is testing

Observational Study to Evaluate the Safety of CYD Tetravalent Dengue Vaccine (CYD-TDV) in Pregnant Women and Their Offsprings Inadvertently Exposed During Pregnancy

Who this might be right for
Dengue Virus Infection
Sanofi Pasteur, a Sanofi Company 104
Not applicableLooking for participantsNCT04486638
What this trial is testing

Dengvaxia US Pregnancy Registry

Who this might be right for
Dengue Virus Infection
Sanofi Pasteur, a Sanofi Company 500
Not applicableStudy completedNCT04048837
What this trial is testing

Prospective Study for the Evaluation of Dengue Prognostic Biomarkers in Singapore

Who this might be right for
Dengue Hemorrhagic FeverDengue Shock SyndromeSevere Dengue
National University Hospital, Singapore 200
Not applicableStudy completedNCT01983553
What this trial is testing

Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study

Who this might be right for
DengueDengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 3,203
Testing effectiveness (Phase 2)Study completedNCT02741128
What this trial is testing

Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverHuman Immunodeficiency Virus
Sanofi Pasteur, a Sanofi Company 133
Testing effectiveness (Phase 2)Study completedNCT00730288
What this trial is testing

Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects

Who this might be right for
DengueDengue FeverDengue Hemorrhagic Fever+1 more
Sanofi 35
Large-scale testing (Phase 3)Ended earlyNCT02992418
What this trial is testing

Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 688
Testing effectiveness (Phase 2)Active Not RecruitingNCT05611710
What this trial is testing

Anakinra in Dengue With Hyperinflammation ( AnaDen )

Who this might be right for
DengueDengue With Warning SignsSevere Dengue+6 more
Oxford University Clinical Research Unit, Vietnam 160
Early research (Phase 1)Study completedNCT01702857
What this trial is testing

A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)

Who this might be right for
Dengue Fever
U.S. Army Medical Research and Development Command 100
Testing effectiveness (Phase 2)UnknownNCT06071481
What this trial is testing

Role of Vitamin D in Prevention of Dengue Haemorrhagic Fever and Dengue Shock Syndrome

Who this might be right for
Dengue Fever
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 120
Early research (Phase 1)Looking for participantsNCT07706686
What this trial is testing

Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection

Who this might be right for
Healthy VolunteersDengueHuman Challenge Trial
National Institute of Allergy and Infectious Diseases (NIAID) 200
Testing effectiveness (Phase 2)Study completedNCT02824198
What this trial is testing

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 118
Not applicableUnknownNCT06255509
What this trial is testing

Dengue Virus Infection Amongst Patients With Acute Febrile Illness

Who this might be right for
Dengue
Tangerang District Hospital 400
Early research (Phase 1)Study completedNCT00322946
What this trial is testing

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy Adults

Who this might be right for
Dengue
National Institute of Allergy and Infectious Diseases (NIAID) 84
Testing effectiveness (Phase 2)Study completedNCT00617344
What this trial is testing

Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US

Who this might be right for
Dengue FeverDengue Hemorrhagic FeverDengue Virus
Sanofi 260
Not applicableStudy completedNCT06697041
What this trial is testing

Clinical and Laboratory Factors for the Progression of Severe Dengue Among Hospitalized Patients During an Upsurge

Who this might be right for
Dengue Fever With Warning Signs
International Centre for Diarrhoeal Disease Research, Bangladesh 324
Not applicableStudy completedNCT04170140
What this trial is testing

Study on Prescribers' Knowledge and Understanding of Safety Messages Following Dengvaxia® Product Information Update

Who this might be right for
Dengue Virus Infection
Sanofi Pasteur, a Sanofi Company 300
Testing effectiveness (Phase 2)Study completedNCT00842530
What this trial is testing

Efficacy and Safety of Dengue Vaccine in Healthy Children

Who this might be right for
Dengue VirusDengue FeverDengue Hemorrhagic Fever+1 more
Sanofi Pasteur, a Sanofi Company 4,002
Not applicableUnknownNCT04422782
What this trial is testing

New Tools for Predicting Capillary Leak Shock During Dengue Fever

Who this might be right for
Dengue FeverChildrenAdults
Centre Hospitalier de Cayenne 342
Next Page